Blog Category: Neurology

Podcast Episode…

New to the diagnosis of major depressive disorder as of DSM-5 is the specifier “with mixed features.” According to DSM-5, “specifiers provide an opportunity to define a more homogeneous subgrouping of individuals with the disorder who share certain features (e.g., …

Researchers from UC San Francisco have completed the first Internet-based clinical trial for children with autism, establishing it as a viable and cost effective method of conducting high-quality and rapid clinical trials in this population.[More…]…

Live today,  neuroscienceCME Live and On Demand Bipolar Disorder – A Focus on Depression. [More…]…

Researchers have taken an important step towards understanding how the human brain ‘decodes’ letters on a page to read words. [More…]…

A new study published in Biological Psychiatry provides new evidence that stimulating the brain using repetitive transcranial magnetic stimulation (rTMS) may be an effective strategy to improve cognitive function. A randomized, 4-week controlled trial (n=27) evaluated whether rTMS can improve …

Discontinuation of treatment in schizophrenia results in very high relapse rates, even after a single psychotic episode. A new review in BMC Psychiatry asserts that multiple relapses characterze the course of illness in most patients with schizophrenia, yet the nature …

Research published this month in Neurology, shows that stroke may be affecting people at a younger age. Researchers looked at occurrences of strokes in people between the ages 20 and 54 in the Greater Cincinnati/Northern Kentucky area during three …

An interesting review in ISRN Pharmacology, a peer-reviewed, open access journal, describes that for the last 60 years, antipsychotic pharmacology targeting antagonism of dopamine (DA) D2 receptors have been the primary treatment choice for schizophrenia. The clinical improvement seen …